MB MAINLINE BIOSCIENCES Trademark

Trademark Overview


On Thursday, November 17, 2022, a trademark application was filed for MB MAINLINE BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MB MAINLINE BIOSCIENCES trademark a serial number of 97682024. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 30, 2024. This trademark is owned by Mainline Biosciences (Shanghai) Co., Ltd.. The MB MAINLINE BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals

General Information


Serial Number97682024
Word MarkMB MAINLINE BIOSCIENCES
Filing DateThursday, November 17, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements


Description of MarkThe mark consists of a stylized "M" to the left of a stylized "B" to the left of the stylized wording "MAINLINE BIOSCIENCE".
Goods and ServicesPharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Trademark Events


Event DateEvent Description
Monday, November 21, 2022NEW APPLICATION ENTERED
Friday, December 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Friday, September 1, 2023NON-FINAL ACTION E-MAILED
Friday, September 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 22, 2024ASSIGNED TO LIE
Monday, April 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 30, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 30, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, April 30, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 30, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, April 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, November 30, 2024TEAS STATEMENT OF USE RECEIVED